94 -12 (86) 2025 - Sharafiy T.F. - FEATURES OF THE DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

FEATURES OF THE DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Sharafiy T.F. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Type 2 diabetes mellitus is one of the most pressing problems of modern medicine due to its high prevalence and significant contribution to cardiovascular morbidity and mortality. This article presents a comprehensive analysis of the pathogenetic mechanisms, clinical characteristics, and risk factors associated with the development of cardiovascular complications in patients with type 2 diabetes mellitus. Based on the analysis of national and international scientific sources, it has been established that chronic hyperglycemia, insulin resistance, arterial hypertension, and dyslipidemia play a key role in the formation of atherosclerotic vascular lesions. The importance of early diagnosis, comprehensive treatment, and preventive measures in reducing the incidence of cardiovascular complications and improving prognosis in this group of patients is emphasized.

Keywords: type 2 diabetes mellitus, cardiovascular diseases, hyperglycemia, atherosclerosis, arterial hypertension, insulin resistance

First page

522

Last page

524

For citation:Sharafiy T.F. - FEATURES OF THE DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS//New Day in Medicine 12(86)2025 522-524 https://newdayworldmedicine.com/en/new_day_medicine/12-86-2025

List of References

1. World Health Organization. Global report on diabetes. Geneva: WHO; 2021.
2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels; 2021.
3. American Diabetes Association. Cardiovascular disease and risk management in diabetes. Diabetes Care. 2022;45(Suppl 1):S144–S174.
4. Libby P. Diabetes and cardiovascular disease: pathophysiology. Circulation. 2019;139(7):e39–e51.
5. Dedov I.I., Shestakova M.V. Сахарный диабет и сердечно-сосудистые осложнения. Москва: ГЭОТАР-Медиа; 2020.
6. Cosentino F. et al. Diabetes, prediabetes, and cardiovascular risk. Eur Heart J. 2020;41(2):255–323.
7. Standl E., Schnell O. Silent myocardial ischemia in diabetes. Diabetologia. 2018;61(8):1607–1616.
8. Ziegler D. Cardiovascular autonomic neuropathy in diabetes. Diabetes Care. 2019;42(1):S100–S106.

   file

   download